Trial Profile
Efficacy and Safety of Eculizumab in Calcineurin Induced Thrombotic Microangiopathy After Non-Renal Solid Organ Transplantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2014
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Thrombotic microangiopathy
- Focus Adverse reactions; Therapeutic Use
- 17 Jun 2014 New trial record